NCT07302113

Brief Summary

This project will work closely with patients to design and test a new program that supports brain health in children and youth with childhood-onset lupus (cSLE). The investigators will see how practical and helpful the program is for patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

November 18, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

May 1, 2026

Status Verified

December 1, 2025

Enrollment Period

12 months

First QC Date

November 18, 2025

Last Update Submit

April 27, 2026

Conditions

Keywords

lupuspsychological interventionadolescentcognitive

Outcome Measures

Primary Outcomes (5)

  • Number of participants recruited

    Feasibility will be assessed by rates of participant recruitment.

    1 year

  • Number of intervention sessions attended

    Feasibility will be assessed by rates of participant session attendance.

    through study completion, an average of 1 year

  • Number of participants completing the intervention

    Feasibility will be assessed by rates of participant intervention completion.

    through study completion, an average of 1 year

  • Acceptability ratings

    Participant acceptability will be determined ratings of their satisfaction with aspects of the program on a brief survey using 5-point Likert scales (ranging from "dissatisfied" to "extremely satisfied").

    0-2 weeks post-intervention

  • Qualitative feedback on feasibility and acceptability of the intervention

    Semi- structured interviews administered to participants post-intervention will also assess intervention feasibility and acceptability.

    0-2 weeks post-intervention

Secondary Outcomes (7)

  • Depressive symptoms

    Baseline and 10 weeks

  • Anxiety symptoms

    Baseline and 10 weeks

  • Executive function

    Baseline and 10 weeks

  • Self-efficacy

    Baseline and 10 weeks

  • Social engagement

    Baseline and 10 weeks

  • +2 more secondary outcomes

Study Arms (1)

TOPS

EXPERIMENTAL
Behavioral: Lupus Teen Online Problem Solving program

Interventions

The Lupus Teen Online Problem Solving program is a brain health intervention developed to meet the needs of youth with childhood-onset lupus. The original Teen Online Problem Solving Program (TOPS) was developed for use with families impacted by traumatic brain injury. The Lupus Teen Online Problem Solving program is based on TOPS, with modifications to maximize relevance and accessibility. The intervention is a 10 session, evidence-based telehealth program providing training in problem-solving, emotion regulation, and communication skills in a one-to-one therapist-mediated design.

TOPS

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Receive subject-informed consent;
  • Have a current diagnosis of cSLE that meets the 1997 American College of Rheumatology (ACR) or System Lupus International Collaborating Clinics (SLICC) classification criteria
  • Aged 13-18 years old

You may not qualify if:

  • Conditions that significantly affect cognition (e.g., intellectual disability diagnosis, active psychosis), hearing loss or vision problems precluding participation in group
  • Non-English speaking
  • Lack of access to technology that would allow them to participate in the virtual intervention (e.g., phone, tablet, computer, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G 1E8, Canada

RECRUITING

Study Officials

  • Busi Zapparoli, PhD

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR
  • Andrea Knight, MD, MSCE

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Investigator

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 24, 2025

Study Start

January 15, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

May 1, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Data will shared upon request and approval of the study plan by the PI, and when the appropriate data use agreement and ethical protocols are in place.

Locations